Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …

Background We evaluated the incidence of invasive pulmonary aspergillosis among
intubated patients with critical COVID-19 and evaluated different case definitions of invasive …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel β-coronavirus,
is the main pathogenic agent of the rapidly spreading pneumonia called coronavirus …

Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …

Pneumonia caused by severe acute respiratory syndrome coronavirus 2 emerged in China
at the end of 2019. Because of the severe immunomodulation and lymphocyte depletion …

Aspergillosis refers to a spectrum of illness that is dependent on host factors and the
immunologic response. Noninvasive forms include allergic bronchopulmonary aspergillosis …

Acute respiratory distress syndrome is a common complication of severe viral pneumonia,
such as influenza and COVID‐19, that requires critical care including ventilatory support …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Rationale: Whether severe coronavirus disease (COVID-19) is a significant risk factor for the
development of invasive fungal superinfections is of great medical interest and remains, for …